TOLLIP and disease arising from reactivation of latent virus: Li et al. found that TOLLIP can inhibit the activity of LTRs from multiple HIV-1 subtypes, and TOLLIP knockout in primary CD+ T cells can promote the activation of HIV from latent infection [7].